Huntington's Disease clinical trials
25 active trials name this condition. Describe your situation to see which ones look like a fit.
Refine by biomarker
By location
- Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
- Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease
- A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Digital Measures for Clinical Trial Endpoints in Huntington's Disease
- Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping
- Cognitive Assessment Tools for Huntington's Disease.
- Gut Microbiomes in HD
- Longitudinal Endpoint Assessment of Disease Burden in HD
- Extracellular Vesicles for HD
- HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- University of Central Florida CereBank
- FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
- NYSCF Scientific Discovery Biobank
- Retinal Imaging in Neurodegenerative Disease
- Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease
- Social Cognition Training in Individuals With Huntington's Disease
- Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Multi-Modal Digital Monitoring of Disease Symptoms Huntington's Disease
- Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study
- Gait Analysis in Neurological Disease
- Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Huntington's Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.